| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 77.54▼ | 77.46▼ | 76.74▲ | 75.65▲ | 72.95▲ |
| MA10 | 77.49▼ | 76.62▲ | 75.77▲ | 75.41▲ | 72.69▲ |
| MA20 | 77.22▲ | 75.81▲ | 76.00▲ | 70.99▲ | 76.23▲ |
| MA50 | 75.72▲ | 75.98▲ | 75.65▲ | 73.23▲ | 70.82▲ |
| MA100 | 75.91▲ | 75.51▲ | 72.16▲ | 76.97▲ | 50.72▲ |
| MA200 | 75.77▲ | 71.96▲ | 67.69▲ | 75.09▲ | 26.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.053▼ | 0.274▲ | 0.167▲ | 1.032▲ | -0.891▼ |
| RSI | 59.281▲ | 59.638▲ | 58.460▲ | 58.517▲ | 52.738▲ |
| STOCH | 70.610 | 85.053▲ | 59.517 | 75.090 | 40.603 |
| WILL %R | -38.732 | -14.550▲ | -14.550▲ | -11.485▲ | -41.442 |
| CCI | -2.402 | 67.902 | 101.579▲ | 75.896 | 2.118 |
|
Sunday, July 19, 2026 06:06 AM
Merck (NYSE:MRK) received FDA approval for Lipfendra (enlicitide), the first oral PCSK9 cholesterol-lowering drug. Lipfendra introduces an oral option for patients who have so far relied on injectable ...
|
|
Tuesday, July 14, 2026 04:10 AM
Eyes are on the rollout of Lilly's new weight loss pill.
|
|
Monday, July 13, 2026 01:24 PM
VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S.A. to support ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/07/26 | 75.60 | 77.94 | 75.60 | 77.39 | 81,199 |
| 20/07/26 | 75.32 | 78.10 | 74.125 | 74.61 | 211,780 |
| 17/07/26 | 73.11 | 79.20 | 73.11 | 76.12 | 157,243 |
| 16/07/26 | 74.575 | 77.55 | 73.00 | 74.23 | 329,527 |
| 15/07/26 | 73.29 | 77.175 | 71.05 | 75.92 | 296,600 |
| 14/07/26 | 76.11 | 77.50 | 73.6907 | 74.03 | 249,122 |
| 13/07/26 | 76.44 | 76.99 | 73.01 | 75.93 | 389,929 |
| 10/07/26 | 77.95 | 78.26 | 71.22 | 77.84 | 331,066 |
| 09/07/26 | 70.38 | 78.85 | 70.38 | 78.20 | 218,573 |
| 08/07/26 | 63.44 | 70.24 | 63.44 | 69.88 | 253,444 |
|
|
||||
|
|
||||
|
|